FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Denver, Colorado1 trial

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)

Rocky Mountain Cancer Center - Primary

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.